Dennis A. Ausiello, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 8,165 shares at $130.02 ($1.1M) on 2015-04-21, disclosed to the SEC on 2015-04-23.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALNY | SELL | 2022-11-23 | $5.0M | — | Filing → |
| ALNY | SELL | 2018-03-14 | $2.6M | — | Filing → |
| ALNY | SELL | 2017-11-03 | $2.6M | — | Filing → |